Evidence map›Paper›PMID 40475991›Full record

ReviewFrontiers in endocrinology2025

Dual triggering for final oocyte maturation. A narrative review.

Adriana Riobó, Andrea Martínez Acosta, Lorena Martinez-Rocca, Esther Taboas, Belén López de Uralde, Iria Fernandez, Nicolás Garrido, Elkin Muñoz

Abstract readReview
In one paragraph

Review in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Adriana RiobóIVIRMA GLOBAL Research Alliance, IVI Coruña, A Coruña, Spain.
Andrea Martínez AcostaIVIRMA GLOBAL Research Alliance, IVI Vigo, Vigo, Spain.
Lorena Martinez-RoccaIVIRMA GLOBAL Research Alliance, IVI Vigo, Vigo, Spain.
Esther TaboasIVIRMA GLOBAL Research Alliance, IVI Vigo, Vigo, Spain.
Belén López de UraldeIVIRMA GLOBAL Research Alliance, IVI Coruña, A Coruña, Spain.
Iria FernandezIVIRMA GLOBAL Research Alliance, IVI Vigo, Vigo, Spain.
Nicolás GarridoIVIRMA GLOBAL Research Alliance, IVI Foundation - Instituto de Investigación Sanitaria La Fe (IISLa Fe), Valencia, Spain.
Elkin MuñozIVIRMA GLOBAL Research Alliance, IVI Coruña, A Coruña, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The dual triggering combines human chorionic gonadotropin (hCG) with GnRH agonists (aGnRH) to induce the final oocyte maturation in

Indexed as

Chorionic GonadotropinFertilization in VitroGonadotropin-Releasing HormoneIn Vitro Oocyte Maturation TechniquesOocytesOogenesisOvulation InductionFemaleHumansPregnancyChorionic GonadotropinGonadotropin-Releasing Hormoneclinical pregnancy ratedual triggeringfinal oocyte maturationGnRH agonistshCGimmature oocytes retrievedlive birth ratelow ovarian responders

Identifiers

PMID40475991
PMCPMC12138522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.